• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Asian Paints Ltd
Industry :  Paints / Varnishes
BSE Code
ISIN Demat
Book Value()
500820
INE021A01026
216.6556261
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ASIANPAINT
48.67
230806.97
EPS(TTM)
Face Value()
Div & Yield %
49.44
1
1.14
 

t&han energies ltd
Caplin Point Laboratories' arm receives Form 483 with 10 observations from USFDA
Aug 22,2026
The inspection was carried out from 13 August 2026 to 21 August 2026. At the conclusion of the inspection, the company received Form 483 containing 10 observations.

The company said that the observations were procedural in nature and did not pertain to data integrity. It also stated that none of the observations were repeat observations.

Caplin Point Laboratories is a fully integrated pharmaceutical company with a strong presence in Latin America. The company’s consolidated net profit jumped 18.79% YoY to Rs 176.91 crore in Q1 FY27. Net sales increased 19.63% to Rs 610.36 crore in Q1 FY27 from Rs 510.22 crore in Q1 FY26.

The counter increased 1.09% to settle at Rs 2558.10 on Friday, 21 August 2026.